Skip to main content

Adma Biologics: Q4 Earnings Snapshot

RAMSEY, N.J. (AP) — RAMSEY, N.J. (AP) — Adma Biologics Inc. (ADMA) on Wednesday reported fourth-quarter earnings of $49.4 million.

On a per-share basis, the Ramsey, New Jersey-based company said it had net income of 20 cents.

The infectious disease drug developer posted revenue of $139.2 million in the period.

For the year, the company reported profit of $146.9 million, or 60 cents per share. Revenue was reported as $510.2 million.

Adma Biologics expects full-year revenue of $635 million.

Adma Biologics shares have dropped 14% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $15.68, a rise of nearly 2% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADMA at https://www.zacks.com/ap/ADMA

One Tech Tip: What to know about flying with lithium ion portable battery chargers

Jetting off soon for summer travels? If you're planning on bringing an extra battery charger for your phone or other devices, be aware of the latest rules when taking one on a flight. Rechargeable lithium-ion portable battery chargers, also known as power banks, come in protective enclosures of various shapes and sizes. They're a handy and popular way for getting more juice when you're on the move. But after a spate of smoke or fire incidents, U.S. and international aviation authorities have issued new guidelines and airlines have tightened up rules for passengers. Here's a guide on flying with power banks.
Read Next Story